Skip to main content

Zevra Therapeutics, Inc 10-Q for FY2022 Q3

Zevra Therapeutics, Inc. (ZVRA)

10-Q 2022-11-10 For: 2022-09-30
View Original
Added on April 10, 2026

About this 10-Q

Zevra Therapeutics, Inc filed this 10-Q on November 10, 2022, covering the quarter ended September 30, 2022 (FY2022 Q3).

Headline figures

Quarter ended September 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$2.87M
up 46.3% from $1.97M a year earlier
Net loss
$6.62M
compared with a net loss of $1.76M a year earlier